ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

NCCN and Flatiron Health Announce Collaboration to Improve Cancer Care Quality with Real-World Data

Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research using real-world data (RWD), today announced the renewal of their collaboration with the National Comprehensive Cancer Network® (NCCN®), an alliance of leading cancer centers devoted to patient care, research, and education. The collaboration between Flatiron and the NCCN dates back to 2014, when Flatiron Health first launched a cloud-based repository of NCCN Member Institution data—the NCCN Quality & Outcomes Database.

“We strive to ensure that everyone, everywhere, is able to access high-quality cancer care based on the latest evidence and expert consensus,” said Crystal S. Denlinger, MD, Chief Executive Officer, NCCN. “This ongoing collaboration with Flatiron will help us leverage data in pursuit of that goal. We are happy to renew our commitment to work together to help people with cancer live better lives.”

This latest extension and refresh of the decade-long collaboration represents an opportunity to build upon a longstanding relationship to enable research with real-world data, create a meaningful impact on cancer care, allow cancer centers across the country to have access to Flatiron’s high-quality, curated data sets, and evaluate and enhance the quality of care given at their sites.

Additionally, Flatiron and NCCN will continue to work together to support quality improvement initiatives at participating NCCN Member Institutions through the continued development of metrics and benchmarks to assess, measure, and impact quality of care.

“The continuation of Flatiron’s long-standing relationship with NCCN is an exciting opportunity and step forward in executing our mission to improve and extend lives by learning from the experience of every person with cancer,” said Neal Meropol, MD, Vice President of Research Oncology, Flatiron Health. “This collaboration will expand the impact of real-world data in addressing evidence gaps and improving care standards along with leading cancer centers in the NCCN alliance.”

For more information, visit NCCN.org and www.flatiron.com.

About Flatiron Health

Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients’ real-life experiences into knowledge and create a more modern, connected oncology ecosystem. Flatiron Health is an independent affiliate of the Roche Group. Flatiron.com @FlatironHealth

About The National Comprehensive Cancer Network

The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. Visit NCCN.org for more information on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and other initiatives.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.41
+0.00 (0.00%)
AAPL  268.47
+0.00 (0.00%)
AMD  233.54
+0.00 (0.00%)
BAC  53.20
+0.00 (0.00%)
GOOG  279.70
+0.00 (0.00%)
META  621.71
+0.00 (0.00%)
MSFT  496.82
+0.00 (0.00%)
NVDA  188.15
+0.00 (0.00%)
ORCL  239.26
+0.00 (0.00%)
TSLA  429.52
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.